Loading...

Optiscan Imaging

ASX:OIL
Snowflake Description

Adequate balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
OIL
ASX
A$15M
Market Cap
  1. Home
  2. AU
  3. Healthcare
Company description

Optiscan Imaging Limited engages in the development and application of confocal microscope imaging technologies for medical, translational, and pre-clinical markets in Australia, North America, Europe, and Asia. The last earnings update was 51 days ago. More info.


Add to Portfolio Compare Print
  • Optiscan Imaging has significant price volatility in the past 3 months.
OIL Share Price and Events
7 Day Returns
2.9%
ASX:OIL
4.1%
AU Medical Equipment
-0%
AU Market
1 Year Returns
-52.7%
ASX:OIL
-3.3%
AU Medical Equipment
4.9%
AU Market
OIL Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Optiscan Imaging (OIL) 2.9% -25.5% -22.2% -52.7% - -30%
AU Medical Equipment 4.1% 0.9% 0.8% -3.3% 38.7% 103.7%
AU Market -0% 1.5% 6.5% 4.9% 18.2% 4.8%
1 Year Return vs Industry and Market
  • OIL underperformed the Medical Equipment industry which returned -3.3% over the past year.
  • OIL underperformed the Market in Australia which returned 4.9% over the past year.
Price Volatility
OIL
Industry
5yr Volatility vs Market

Value

 Is Optiscan Imaging undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Optiscan Imaging. This is due to cash flow or dividend data being unavailable. The share price is A$0.035.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Optiscan Imaging's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Optiscan Imaging's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ASX:OIL PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in AUD A$-0.01
ASX:OIL Share Price ** ASX (2019-04-17) in AUD A$0.04
Australia Medical Equipment Industry PE Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 33.38x
Australia Market PE Ratio Median Figure of 545 Publicly-Listed Companies 16.18x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Optiscan Imaging.

ASX:OIL PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:OIL Share Price ÷ EPS (both in AUD)

= 0.04 ÷ -0.01

-6.83x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Optiscan Imaging is loss making, we can't compare its value to the AU Medical Equipment industry average.
  • Optiscan Imaging is loss making, we can't compare the value of its earnings to the Australia market.
Price based on expected Growth
Does Optiscan Imaging's expected growth come at a high price?
Raw Data
ASX:OIL PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -6.83x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Oceania Medical Equipment Industry PEG Ratio Median Figure of 5 Publicly-Listed Medical Equipment Companies 2.62x
Australia Market PEG Ratio Median Figure of 360 Publicly-Listed Companies 1.37x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Optiscan Imaging, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Optiscan Imaging's assets?
Raw Data
ASX:OIL PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in AUD A$0.01
ASX:OIL Share Price * ASX (2019-04-17) in AUD A$0.04
Australia Medical Equipment Industry PB Ratio Median Figure of 30 Publicly-Listed Medical Equipment Companies 2.72x
Australia Market PB Ratio Median Figure of 1,676 Publicly-Listed Companies 1.67x
ASX:OIL PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:OIL Share Price ÷ Book Value per Share (both in AUD)

= 0.04 ÷ 0.01

6.84x

* Primary Listing of Optiscan Imaging.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Optiscan Imaging is overvalued based on assets compared to the AU Medical Equipment industry average.
X
Value checks
We assess Optiscan Imaging's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Optiscan Imaging has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Optiscan Imaging expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Optiscan Imaging has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
13.2%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Optiscan Imaging expected to grow at an attractive rate?
  • Unable to compare Optiscan Imaging's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Optiscan Imaging's earnings growth to the Australia market average as no estimate data is available.
  • Unable to compare Optiscan Imaging's revenue growth to the Australia market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
ASX:OIL Future Growth Rates Data Sources
Data Point Source Value (per year)
Australia Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 13.2%
Australia Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 8.4%
Australia Market Earnings Growth Rate Market Cap Weighted Average 6.5%
Australia Market Revenue Growth Rate Market Cap Weighted Average 3.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ASX:OIL Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ASX:OIL Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-12-31 2 -1 -2
2018-09-30 2 -2 -2
2018-06-30 2 -2 -2
2018-03-31 2 -3 -2
2017-12-31 2 -4 -2
2017-09-30 2 -4 -2
2017-06-30 1 -3 -3
2017-03-31 1 -2 -3
2016-12-31 1 -1 -3
2016-09-30 0 -1 -2
2016-06-30 0 -1 -1
2016-03-31 0 -1 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Optiscan Imaging is high growth as no earnings estimate data is available.
  • Unable to determine if Optiscan Imaging is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ASX:OIL Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Optiscan Imaging Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:OIL Past Financials Data
Date (Data in AUD Millions) EPS *
2018-12-31 -0.01
2018-09-30 -0.01
2018-06-30 0.00
2018-03-31 0.00
2017-12-31 0.00
2017-09-30 -0.01
2017-06-30 -0.01
2017-03-31 -0.01
2016-12-31 -0.01
2016-09-30 -0.01
2016-06-30 -0.01
2016-03-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Optiscan Imaging will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Optiscan Imaging's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Optiscan Imaging's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Optiscan Imaging's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Optiscan Imaging's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Optiscan Imaging has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Optiscan Imaging performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Optiscan Imaging's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Optiscan Imaging does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Optiscan Imaging's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Optiscan Imaging's 1-year growth to the AU Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Optiscan Imaging's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Optiscan Imaging Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:OIL Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 1.82 -2.21 1.78 1.51
2018-09-30 2.00 -2.12 2.03 1.74
2018-06-30 2.19 -2.04 2.28 1.97
2018-03-31 2.06 -1.91 1.90 2.07
2017-12-31 1.93 -1.78 1.83 2.16
2017-09-30 1.63 -2.36 2.10 2.18
2017-06-30 1.33 -2.94 2.36 2.21
2017-03-31 0.97 -2.85 2.33 1.81
2016-12-31 0.61 -2.75 2.29 1.40
2016-09-30 0.46 -2.05 1.72 1.34
2016-06-30 0.31 -1.34 1.15 1.27
2016-03-31 0.17 -1.32 1.17 1.27
2015-12-31 0.03 -1.29 1.19 1.27
2015-09-30 0.04 -1.34 1.25 1.17
2015-06-30 0.05 -1.40 1.32 1.07
2015-03-31 0.07 -1.22 1.16 1.11
2014-12-31 0.08 -1.05 1.01 1.15
2014-09-30 0.08 -1.23 1.02 1.20
2014-06-30 0.08 -1.42 1.02 1.26
2014-03-31 0.08 -1.71 1.22 1.37
2013-12-31 0.08 -2.00 1.41 1.48
2013-09-30 0.52 -1.32 1.47 1.50
2013-06-30 0.97 -0.64 1.52 1.52
2013-03-31 1.01 -1.08 1.71 1.33
2012-12-31 1.05 -1.52 1.89 1.14
2012-09-30 0.72 -2.01 1.88 1.17
2012-06-30 0.38 -2.50 1.87 1.19

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Optiscan Imaging has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Optiscan Imaging has efficiently used its assets last year compared to the AU Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Optiscan Imaging improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Optiscan Imaging's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Optiscan Imaging has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Optiscan Imaging's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Optiscan Imaging's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Optiscan Imaging is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Optiscan Imaging's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Optiscan Imaging's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Optiscan Imaging has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Optiscan Imaging Company Filings, last reported 3 months ago.

ASX:OIL Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 2.21 0.00 1.04
2018-09-30 2.21 0.00 1.04
2018-06-30 3.20 0.00 1.56
2018-03-31 3.20 0.00 1.56
2017-12-31 4.10 0.00 2.27
2017-09-30 4.10 0.00 2.27
2017-06-30 1.67 0.00 0.70
2017-03-31 1.67 0.00 0.70
2016-12-31 2.26 0.03 2.49
2016-09-30 2.26 0.03 2.49
2016-06-30 -0.75 1.12 0.95
2016-03-31 -0.75 1.12 0.95
2015-12-31 -0.19 0.85 0.92
2015-09-30 -0.19 0.85 0.92
2015-06-30 -0.18 0.51 0.27
2015-03-31 -0.18 0.51 0.27
2014-12-31 0.04 0.39 0.91
2014-09-30 0.04 0.39 0.91
2014-06-30 -0.18 0.13 0.07
2014-03-31 -0.18 0.13 0.07
2013-12-31 -0.14 0.14 0.34
2013-09-30 -0.14 0.14 0.34
2013-06-30 0.95 0.00 0.43
2013-03-31 0.95 0.00 0.43
2012-12-31 1.63 0.10 0.82
2012-09-30 1.63 0.10 0.82
2012-06-30 0.31 0.21 0.58
  • Optiscan Imaging has no debt.
  • Optiscan Imaging currently has no debt however we can't compare to 5 years ago as we have no data for that period.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Optiscan Imaging has less than a year of cash runway based on current free cash flow.
  • Optiscan Imaging has less than a year of cash runway if free cash flow continues to grow at historical rates of 28.8% each year.
X
Financial health checks
We assess Optiscan Imaging's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Optiscan Imaging has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Optiscan Imaging's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Optiscan Imaging dividends.
If you bought A$2,000 of Optiscan Imaging shares you are expected to receive A$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Optiscan Imaging's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Optiscan Imaging's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ASX:OIL Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Oceania Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 1.7%
Australia Market Average Dividend Yield Market Cap Weighted Average of 417 Stocks 4.3%
Australia Minimum Threshold Dividend Yield 10th Percentile 1.6%
Australia Bottom 25% Dividend Yield 25th Percentile 2.5%
Australia Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Optiscan Imaging has not reported any payouts.
  • Unable to verify if Optiscan Imaging's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Optiscan Imaging's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Optiscan Imaging has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Optiscan Imaging's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Optiscan Imaging afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Optiscan Imaging has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Optiscan Imaging's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • Optiscan Imaging has no CEO, or we have no data on them.
Management Team

Darren Lurie

TITLE
Executive Chairman
COMPENSATION
A$212K

Justin Mouchacca

TITLE
CFO & Company Secretary
COMPENSATION
A$78K
TENURE
2.1 yrs

Peter Delaney

TITLE
Consultant
COMPENSATION
A$158K
AGE
50
TENURE
0.4 yrs
Board of Directors Tenure

Average tenure of the Optiscan Imaging board of directors in years:

1
Average Tenure
  • The average tenure for the Optiscan Imaging board of directors is less than 3 years, this suggests a new board.
Board of Directors

Darren Lurie

TITLE
Executive Chairman
COMPENSATION
A$212K
TENURE
0.9 yrs

Philip Currie

TITLE
Non-Executive Director
COMPENSATION
A$42K
TENURE
1.8 yrs

Graeme Mutton

TITLE
Non Executive Director
COMPENSATION
A$10K
TENURE
1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (A$) Value (A$)
X
Management checks
We assess Optiscan Imaging's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Optiscan Imaging has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Does Optiscan Imaging Limited (ASX:OIL) Have A Volatile Share Price?

Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). … While we should keep in mind that Warren Buffett has cautioned that 'Volatility is far from synonymous with risk', beta is still a useful factor to consider. … A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.

Simply Wall St -

What Investors Should Know About Optiscan Imaging Limited's (ASX:OIL) Financial Strength

The direct benefit for Optiscan Imaging Limited (ASX:OIL), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … Is OIL right in choosing financial flexibility over lower cost of capital … Debt capital generally has lower cost of capital compared to equity funding.

Simply Wall St -

How Much Of Optiscan Imaging Limited (ASX:OIL) Do Insiders Own?

The big shareholder groups in Optiscan Imaging Limited (ASX:OIL) have power over the company. … Generally speaking, as a company grows, institutions will increase their ownership. … See our latest analysis for Optiscan Imaging

Simply Wall St -

Optiscan Imaging Limited (ASX:OIL): Time For A Financial Health Check

The direct benefit for Optiscan Imaging Limited (ASX:OIL), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. … Does OIL's growth rate justify its decision for financial flexibility over lower cost of capital. … Debt capital generally has lower cost of capital compared to equity funding

Simply Wall St -

How Does Optiscan Imaging Limited (ASX:OIL) Affect Your Portfolio Returns?

Generally, an investor should consider two types of risk that impact the market value of OIL. … The first risk to consider is company-specific, which can be diversified away when you invest in other companies in the same industry as OIL, because it is rare that an entire industry collapses at once. … The other type of risk, which cannot be diversified away, is market risk.

Simply Wall St -

How Did Optiscan Imaging Limited's (ASX:OIL) Earnings Growth Stack Up Against The Industry?

Measuring Optiscan Imaging Limited's (ASX:OIL) track record of past performance is a useful exercise for investors. … View our latest analysis for Optiscan Imaging Could OIL beat the long-term trend and outperform its industry? … This suggests that though Optiscan Imaging is currently running a loss, whatever recent headwind the industry is facing, the impact on Optiscan Imaging has been softer relative to its peers.What does this mean?

Simply Wall St -

How Optiscan Imaging Limited (ASX:OIL) Can Impact Your Portfolio Volatility

A widely-used metric to measure a stock's market risk is beta, and the broad market index represents a beta value of one. … OIL's beta implies it may be a stock that investors with high-beta portfolios might find relevant if they wanted to reduce their exposure to market risk, especially during times of downturns. … How OIL's assets could affect its beta An asset-heavy company tends to have a higher beta because the risk associated with running fixed assets during a downturn is highly expensive.

Simply Wall St -

What Does Optiscan Imaging Limited's (ASX:OIL) Ownership Structure Look Like?

Check out our latest analysis for Optiscan Imaging ASX:OIL Ownership_summary Apr 4th 18 Institutional Ownership Institutional investors transact in large blocks which can influence the momentum of stock prices, at least in the short-term, especially when there is a low level of public shares available on the market to trade. … This level of ownership gives retail investors the power to sway key policy decisions such as board composition, executive compensation, and potential acquisitions. … Thus, potential investors should look into these business relations and check how it can impact long-term shareholder returns.Next Steps: With a low level of institutional ownership, investors in OIL need not worry about non-fundamental factors such as ownership structure causing large impact on stock prices.

Simply Wall St -

When Will Optiscan Imaging Limited (ASX:OIL) Run Out Of Cash?

See our latest analysis for Optiscan Imaging What is cash burn? … The measure of how fast Optiscan Imaging goes through its cash reserves over time is called the cash burn rate. … My cash burn analysis suggests that, if Optiscan Imaging continues to spend its cash reserves at this current rate, it’ll have to raise capital within the next 6 months, which may be a surprise to some shareholders.

Simply Wall St -

Interested In Optiscan Imaging Limited (ASX:OIL)? Here's How It's Performing

View our latest analysis for Optiscan Imaging Was OIL weak performance lately part of a long-term decline? … For Optiscan Imaging, its latest trailing-twelve-month earnings is -AU$2.94M, which, in comparison to the prior year's figure, has become more negative. … This shows that whatever recent headwind the industry is facing, it’s hitting Optiscan Imaging harder than its peers.What does this mean?

Simply Wall St -

Company Info

Description

Optiscan Imaging Limited engages in the development and application of confocal microscope imaging technologies for medical, translational, and pre-clinical markets in Australia, North America, Europe, and Asia. It offers ViewnVivo, a miniaturized fluorescence endomicroscope platform that brings imaging flexibility to preclinical research. The company also provides FIVE2 ViewnVivo system that enables virtual biopsies in living, breathing, moving tissue. It has collaboration agreement with Summit Biomedical Imaging LLC. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

Details
Name: Optiscan Imaging Limited
OIL
Exchange: ASX
Founded: 1994
A$15,143,758
432,678,800
Website: http://www.optiscan.com
Address: Optiscan Imaging Limited
16 Miles Street,
Mulgrave,
Victoria, 3170,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX OIL Ordinary Shares Australian Securities Exchange AU AUD 11. Aug 1997
CHIA OIL Ordinary Shares Chi-X Australia AU AUD 11. Aug 1997
Number of employees
Current staff
Staff numbers
0
Optiscan Imaging employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/20 10:31
End of day share price update: 2019/04/17 00:00
Last earnings filing: 2019/02/28
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.